A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in

Administered By

Contributors

Start/End

  • March 14, 2019 - December 31, 2021